{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T20:42:36Z","timestamp":1761597756776},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"S12","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1186\/s12859-016-1194-3","type":"journal-article","created":{"date-parts":[[2016,11,8]],"date-time":"2016-11-08T09:17:07Z","timestamp":1478596627000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Artificial neural network classifier predicts neuroblastoma patients\u2019 outcome"],"prefix":"10.1186","volume":"17","author":[{"given":"Davide","family":"Cangelosi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Pelassa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Morini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Conte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Carla","family":"Bosco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Eva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela Rita","family":"Sementa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Varesio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,11,8]]},"reference":[{"key":"1194_CR1","first-page":"21","volume-title":"Human Cell Culture","author":"CJ Thiele","year":"1999","unstructured":"Thiele CJ. Neuroblastoma. In: Master JRW, Palsson B, editors. Human Cell Culture. London: Kluwer; 1999. p. 21\u20132."},{"key":"1194_CR2","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(07)60983-0","volume":"369","author":"J Maris","year":"2007","unstructured":"Maris J, Hogarty M, Bagatell R, Cohn S. Neuroblastoma. Lancet. 2007;369:2106\u201320.","journal-title":"Lancet"},{"key":"1194_CR3","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/pbc.22470","volume":"54","author":"HN Caron","year":"2010","unstructured":"Caron HN. Are thoracic neuroblastomas really different? Pediatr Blood Cancer. 2010;54:867.","journal-title":"Pediatr Blood Cancer"},{"key":"1194_CR4","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1634\/theoncologist.8-3-278","volume":"8","author":"J Weinstein","year":"2003","unstructured":"Weinstein J, Katzenstein H, Cohn S. Advances in the diagnosis and treatment of neuroblastoma. Oncologist. 2003;8:278\u201392.","journal-title":"Oncologist"},{"key":"1194_CR5","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1200\/JCO.1998.16.10.3286","volume":"16","author":"S Bordow","year":"1998","unstructured":"Bordow S, Norris M, Haber P, Marshall G, Haber M. Prognostic significance of MYCN oncogene expression in childhood neuroblastoma. J Clin Oncol. 1998;16:3286\u201394.","journal-title":"J Clin Oncol"},{"key":"1194_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2003.09.042","volume":"325","author":"MM Noesel van","year":"2004","unstructured":"van Noesel MM, Versteeg R. Pediatric neuroblastomas: genetic and epigenetic \u2018danse macabre\u2019. Gene. 2004;325:1\u201315.","journal-title":"Gene"},{"key":"1194_CR7","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1200\/JCO.2003.03.025","volume":"21","author":"IM Ambros","year":"2003","unstructured":"Ambros IM, Benard J, Boavida M, Bown N, Caron H, Combaret V, et al. Quality assessment of genetic markers used for therapy stratification. J Clin Oncol. 2003;21:2077\u201384.","journal-title":"J Clin Oncol"},{"key":"1194_CR8","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1096\/fj.07-103457","volume":"22","author":"B Sveinbjornsson","year":"2008","unstructured":"Sveinbjornsson B, Rasmuson A, Baryawno N, Wan M, Pettersen I, Ponthan F, et al. Expression of enzymes and receptors of the leukotriene pathway in human neuroblastoma promotes tumor survival and provides a target for therapy. FASEB J. 2008;22:3525\u201336.","journal-title":"FASEB J"},{"key":"1194_CR9","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1200\/JCO.2009.24.8351","volume":"28","author":"R Haupt","year":"2010","unstructured":"Haupt R, Garaventa A, Gambini C, Parodi S, Cangemi G, Casale F, et al. Improved survival of children with neuroblastoma between 1979 and 2005: a report of the Italian Neuroblastoma Registry. J Clin Oncol. 2010;28:2331\u20138.","journal-title":"J Clin Oncol"},{"key":"1194_CR10","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.molonc.2014.01.010","volume":"8","author":"TP Stricker","year":"2014","unstructured":"Stricker TP, La Morales MA, Chlenski A, Guerrero L, Salwen HR, Gosiengfiao Y, et al. Validation of a prognostic multi-gene signature in high-risk neuroblastoma using the high throughput digital NanoString nCounter system. Mol Oncol. 2014;8:669\u201378.","journal-title":"Mol Oncol"},{"issue":"Suppl 5","key":"1194_CR11","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1186\/1471-2105-15-S5-S4","volume":"15","author":"D Cangelosi","year":"2014","unstructured":"Cangelosi D, Muselli M, Parodi S, Blengio F, Becherini P, Versteeg R, et al. Use of Attribute Driven Incremental Discretization and Logic Learning Machine to build a prognostic classifier for neuroblastoma patients. BMC Bioinformatics. 2014;15 Suppl 5:S4.","journal-title":"BMC Bioinformatics"},{"key":"1194_CR12","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/1476-4598-9-185","volume":"9","author":"P Fardin","year":"2010","unstructured":"Fardin P, Barla A, Mosci S, Rosasco L, Verri A, Versteeg R, et al. A biology-driven approach identifies the hypoxia gene signature as a predictor of the outcome of neuroblastoma patients. Mol Cancer. 2010;9:185.","journal-title":"Mol Cancer"},{"key":"1194_CR13","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1158\/1078-0432.CCR-09-2607","volume":"16","author":"K Preter De","year":"2010","unstructured":"De Preter K, Vermeulen J, Brors B, Delattre O, Eggert A, Fischer M, et al. Accurate Outcome Prediction in Neuroblastoma across Independent Data Sets Using a Multigene Signature. Clin Cancer Res. 2010;16:1532\u201341.","journal-title":"Clin Cancer Res"},{"key":"1194_CR14","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.1200\/JCO.2009.27.3367","volume":"28","author":"A Oberthuer","year":"2010","unstructured":"Oberthuer A, Hero B, Berthold F, Juraeva D, Faldum A, Kahlert Y, et al. Prognostic Impact of Gene Expression-Based Classification for Neuroblastoma. J Clin Oncol. 2010;28:3506\u201315.","journal-title":"J Clin Oncol"},{"key":"1194_CR15","first-page":"29","volume":"10","author":"J Vermeulen","year":"2010","unstructured":"Vermeulen J, De Preter K, Mestdagh P, Laureys G, Speleman F, Vandesompele J. Predicting outcomes for children with neuroblastoma. Discov Med. 2010;10:29\u201336.","journal-title":"Discov Med"},{"key":"1194_CR16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1475-2867-11-9","volume":"11","author":"F Abel","year":"2011","unstructured":"Abel F, Dalevi D, Nethander M, Jornsten R, De Preter K, Vermeulen J, et al. A 6-gene signature identifies four molecular subgroups of neuroblastoma. Cancer Cell Int. 2011;11:9\u201311.","journal-title":"Cancer Cell Int"},{"key":"1194_CR17","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1158\/1078-0432.CCR-11-2483","volume":"18","author":"I Garcia","year":"2012","unstructured":"Garcia I, Mayol G, Rios J, Domenech G, Cheung NK, Oberthuer A, et al. A three-gene expression signature model for risk stratification of patients with neuroblastoma. Clin Cancer Res. 2012;18:2012\u201323.","journal-title":"Clin Cancer Res"},{"key":"1194_CR18","doi-asserted-by":"crossref","first-page":"19190","DOI":"10.1073\/pnas.1208215109","volume":"109","author":"LJ Valentijn","year":"2012","unstructured":"Valentijn LJ, Koster J, Haneveld F, Aissa RA, van Sluis P, Broekmans ME, et al. Functional MYCN signature predicts outcome of neuroblastoma irrespective of MYCN amplification. Proc Natl Acad Sci U S A. 2012;109:19190\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1194_CR19","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1002\/ijc.29461","volume":"137","author":"K Stedingk von","year":"2015","unstructured":"von Stedingk K, De Preter K, Vandesompele J, Noguera R, Ora I, Koster J, et al. Individual patient risk stratification of high-risk neuroblastomas using a two-gene score suited for clinical use. Int J Cancer. 2015;137:868\u201377.","journal-title":"Int J Cancer"},{"key":"1194_CR20","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1200\/JCO.2011.40.9169","volume":"30","author":"S Asgharzadeh","year":"2012","unstructured":"Asgharzadeh S, Salo JA, Ji L, Oberthuer A, Fischer M, Berthold F, et al. Clinical significance of tumor-associated inflammatory cells in metastatic neuroblastoma. J Clin Oncol. 2012;30:3525\u201332.","journal-title":"J Clin Oncol"},{"key":"1194_CR21","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1158\/1078-0432.CCR-14-0817","volume":"21","author":"A Oberthuer","year":"2015","unstructured":"Oberthuer A, Juraeva D, Hero B, Volland R, Sterz C, Schmidt R, et al. Revised risk estimation and treatment stratification of low- and intermediate-risk neuroblastoma patients by integrating clinical and molecular prognostic markers. Clin Cancer Res. 2015;21:1904\u201315.","journal-title":"Clin Cancer Res"},{"key":"1194_CR22","volume":"8","author":"E Barbieri","year":"2013","unstructured":"Barbieri E, De Preter K, Capasso M, Johansson P, Man TK, Chen Z, et al. A p53 drug response signature identifies prognostic genes in high-risk neuroblastoma. Plos One. 2013;8, e79843.","journal-title":"Plos One"},{"key":"1194_CR23","doi-asserted-by":"crossref","first-page":"6883","DOI":"10.1158\/0008-5472.CAN-04-0695","volume":"64","author":"J Wei","year":"2004","unstructured":"Wei J, Greer B, Westermann F, Steinberg S, Son C, Chen Q, et al. Prediction of clinical outcome using gene expression profiling and artificial neural networks for patients with neuroblastoma. Cancer Res. 2004;64:6883\u201391.","journal-title":"Cancer Res"},{"key":"1194_CR24","doi-asserted-by":"crossref","first-page":"7902","DOI":"10.1038\/sj.onc.1208936","volume":"24","author":"A Schramm","year":"2005","unstructured":"Schramm A, Schulte JH, Klein-Hitpass L, Havers W, Sieverts H, Berwanger B, et al. Prediction of clinical outcome and biological characterization of neuroblastoma by expression profiling. Oncogene. 2005;24:7902\u201312.","journal-title":"Oncogene"},{"key":"1194_CR25","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ccr.2005.03.019","volume":"7","author":"M Ohira","year":"2005","unstructured":"Ohira M, Oba S, Nakamura Y, Isogai E, Kaneko S, Nakagawa A, et al. Expression profiling using a tumor-specific cDNA microarray predicts the prognosis of intermediate risk neuroblastomas. Cancer Cell. 2005;7:337\u201350.","journal-title":"Cancer Cell"},{"key":"1194_CR26","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1200\/JCO.2006.06.1879","volume":"24","author":"A Oberthuer","year":"2006","unstructured":"Oberthuer A, Berthold F, Warnat P, Hero B, Kahlert Y, Spitz R, et al. Customized oligonucleotide microarray gene expression-based classification of neuroblastoma patients outperforms current clinical risk stratification. J Clin Oncol. 2006;24:5070\u20138.","journal-title":"J Clin Oncol"},{"key":"1194_CR27","doi-asserted-by":"crossref","first-page":"5118","DOI":"10.1158\/1078-0432.CCR-06-0985","volume":"12","author":"M Fischer","year":"2006","unstructured":"Fischer M, Oberthuer A, Brors B, Kahlert Y, Skowron M, Voth H, et al. Differential expression of neuronal genes defines subtypes of disseminated neuroblastoma with favorable and unfavorable outcome. Clin Cancer Res. 2006;12:5118\u201328.","journal-title":"Clin Cancer Res"},{"key":"1194_CR28","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(09)70154-8","volume":"10","author":"J Vermeulen","year":"2009","unstructured":"Vermeulen J, De Preter K, Naranjo A, Vercruysse L, Van Roy N, Hellemans J, et al. Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN\/COG\/GPOH study. Lancet Oncol. 2009;10:663\u201371.","journal-title":"Lancet Oncol"},{"key":"1194_CR29","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1186\/1471-2164-10-474","volume":"10","author":"P Fardin","year":"2009","unstructured":"Fardin P, Barla A, Mosci S, Rosasco L, Verri A, Varesio L. The l1-l2 regularization framework unmasks the hypoxia signature hidden in the transcriptome of a set of heterogeneous neuroblastoma cell lines. BMC Genomics. 2009;10:474.","journal-title":"BMC Genomics"},{"key":"1194_CR30","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.semcancer.2008.11.009","volume":"19","author":"GL Semenza","year":"2009","unstructured":"Semenza GL. Regulation of cancer cell metabolism by hypoxia-inducible factor 1. Semin Cancer Biol. 2009;19:12\u20136.","journal-title":"Semin Cancer Biol"},{"key":"1194_CR31","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/28867","volume":"394","author":"P Carmeliet","year":"1998","unstructured":"Carmeliet P, Dor Y, Herbert JM, Fukumura D, Brusselmans K, Dewerchin M, et al. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature. 1998;394:485\u201390.","journal-title":"Nature"},{"key":"1194_CR32","doi-asserted-by":"crossref","first-page":"949","DOI":"10.4161\/cbt.9.12.12347","volume":"9","author":"Q Lin","year":"2010","unstructured":"Lin Q, Yun Z. Impact of the hypoxic tumor microenvironment on the regulation of cancer stem cell characteristics. Cancer Biol Ther. 2010;9:949\u201356.","journal-title":"Cancer Biol Ther"},{"key":"1194_CR33","doi-asserted-by":"crossref","first-page":"5928","DOI":"10.1158\/1078-0432.CCR-10-1360","volume":"16","author":"X Lu","year":"2010","unstructured":"Lu X, Kang Y. Hypoxia and hypoxia-inducible factors: master regulators of metastasis. Clin Cancer Res. 2010;16:5928\u201335.","journal-title":"Clin Cancer Res"},{"key":"1194_CR34","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2014.52","volume":"4","author":"A Herrmann","year":"2015","unstructured":"Herrmann A, Rice M, Levy R, Pizer BL, Losty PD, Moss D, et al. Cellular memory of hypoxia elicits neuroblastoma metastasis and enables invasion by non-aggressive neighbouring cells. Oncogenesis. 2015;4, e138.","journal-title":"Oncogenesis"},{"key":"1194_CR35","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s10555-007-9063-1","volume":"26","author":"DA Chan","year":"2007","unstructured":"Chan DA, Giaccia AJ. Hypoxia, gene expression, and metastasis. Cancer Metastasis Rev. 2007;26:333\u20139.","journal-title":"Cancer Metastasis Rev"},{"key":"1194_CR36","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.clon.2015.07.004","volume":"27","author":"BH Harris","year":"2015","unstructured":"Harris BH, Barberis A, West CM, Buffa FM. Gene Expression Signatures as Biomarkers of Tumour Hypoxia. Clin Oncol (R Coll Radiol). 2015;27:547\u201360.","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"1194_CR37","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrc704","volume":"2","author":"AL Harris","year":"2002","unstructured":"Harris AL. Hypoxia--a key regulatory factor in tumour growth. Nat Rev Cancer. 2002;2:38\u201347.","journal-title":"Nat Rev Cancer"},{"key":"1194_CR38","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/cdd.2008.21","volume":"15","author":"EB Rankin","year":"2008","unstructured":"Rankin EB, Giaccia AJ. The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ. 2008;15:678\u201385.","journal-title":"Cell Death Differ"},{"key":"1194_CR39","doi-asserted-by":"crossref","unstructured":"Fardin P, Cornero A, Barla A, Mosci S, Acquaviva M, Rosasco L, et al. Identification of Multiple Hypoxia Signatures in Neuroblastoma Cell Lines by l(1)-l(2) Regularization and Data Reduction. J Biomed Biotechnol. 2010;878709.","DOI":"10.1155\/2010\/878709"},{"key":"1194_CR40","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.semcancer.2006.04.005","volume":"17","author":"A Edsjo","year":"2007","unstructured":"Edsjo A, Holmquist L, Pahlman S. Neuroblastoma as an experimental model for neuronal differentiation and hypoxia-induced tumor cell dedifferentiation. Semin Cancer Biol. 2007;17:248\u201356.","journal-title":"Semin Cancer Biol"},{"key":"1194_CR41","doi-asserted-by":"crossref","first-page":"7130","DOI":"10.1158\/1078-0432.CCR-09-0223","volume":"15","author":"R Noguera","year":"2009","unstructured":"Noguera R, Fredlund E, Piqueras M, Pietras A, Beckman S, Navarro S, et al. HIF-1 alpha and HIF-2 alpha Are Differentially Regulated In vivo in Neuroblastoma: High HIF-1 alpha Correlates Negatively to Advanced Clinical Stage and Tumor Vascularization. Clin Cancer Res. 2009;15:7130\u20136.","journal-title":"Clin Cancer Res"},{"key":"1194_CR42","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.yexcr.2004.01.013","volume":"295","author":"A Jogi","year":"2004","unstructured":"Jogi A, Vallon-Christersson J, Holmquist L, Axelson H, Borg A, Pahlman S. Human neuroblastoma cells exposed to hypoxia: induction of genes associated with growth, survival, and aggressive behavior. Exp Cell Res. 2004;295:469\u201387.","journal-title":"Exp Cell Res"},{"key":"1194_CR43","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ccr.2009.02.023","volume":"15","author":"S Huang","year":"2009","unstructured":"Huang S, Laoukili J, Epping MT, Koster J, Holzel M, Westerman BA, et al. ZNF423 is critically required for retinoic acid-induced differentiation and is a marker of neuroblastoma outcome. Cancer Cell. 2009;15:328\u201340.","journal-title":"Cancer Cell"},{"key":"1194_CR44","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/1471-2105-11-183","volume":"11","author":"M Ohtaki","year":"2010","unstructured":"Ohtaki M, Otani K, Hiyama K, Kamei N, Satoh K, Hiyama E. A robust method for estimating gene expression states using Affymetrix microarray probe level data. BMC Bioinformatics. 2010;11:183.","journal-title":"BMC Bioinformatics"},{"key":"1194_CR45","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1200\/JCO.1993.11.8.1466","volume":"11","author":"GM Brodeur","year":"1993","unstructured":"Brodeur GM, Pritchard J, Berthold F, Carlsen NLT, Castel V, Castleberry RP, et al. Revisions of the International Criteria for Neuroblastoma Diagnosis, Staging, and Response to Treatment. J Clin Oncol. 1993;11:1466\u201377.","journal-title":"J Clin Oncol"},{"key":"1194_CR46","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1038\/nbt1296-1675","volume":"14","author":"DJ Lockhart","year":"1996","unstructured":"Lockhart DJ, Dong H, Byrne MC, Follettie MT, Gallo MV, Chee MS, et al. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol. 1996;14:1675\u201380.","journal-title":"Nat Biotechnol"},{"key":"1194_CR47","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/bib\/bbp012","volume":"10","author":"LJ Lancashire","year":"2009","unstructured":"Lancashire LJ, Lemetre C, Ball GR. An introduction to artificial neural networks in bioinformatics--application to complex microarray and mass spectrometry datasets in cancer studies. Brief Bioinform. 2009;10:315\u201329.","journal-title":"Brief Bioinform"},{"key":"1194_CR48","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1016\/S1352-2310(97)00447-0","volume":"32","author":"MW Gardner","year":"1998","unstructured":"Gardner MW, Dorling SR. Artificial neural networks (the multilayer perceptron)\u2014a review of applications in the atmospheric sciences. Atmos Environ. 1998;32:2627\u201336.","journal-title":"Atmos Environ"},{"key":"1194_CR49","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1145\/1961189.1961199","volume":"2","author":"CC Chang","year":"2011","unstructured":"Chang CC, Lin CJ. LIBSVM: A library for support vector machines. ACM Trans Intell Syst Technol. 2011;2:27.","journal-title":"ACM Trans Intell Syst Technol"},{"key":"1194_CR50","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2307\/2347628","volume":"41","author":"S Cessie Le","year":"1992","unstructured":"Le Cessie S, Van Houwelingen JC. Ridge estimators in logistic regression. Appl Stat. 1992;41:191\u2013201.","journal-title":"Appl Stat"},{"key":"1194_CR51","unstructured":"John GH, Langley P. Estimating continuous distributions in Bayesian classifiers. In: Proceedings of the Eleventh conference on Uncertainty in artificial intelligence. Morgan Kaufmann Publishers Inc.San Francisco, CA, USA; 1995:338\u2013345."},{"key":"1194_CR52","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1093\/bioinformatics\/bth261","volume":"20","author":"E Frank","year":"2004","unstructured":"Frank E, Hall M, Trigg L, Holmes G, Witten IH. Data mining in bioinformatics using Weka. Bioinformatics. 2004;20:2479\u201381.","journal-title":"Bioinformatics"},{"key":"1194_CR53","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/bioinformatics\/16.5.412","volume":"16","author":"P Baldi","year":"2000","unstructured":"Baldi P, Brunak S, Chauvin Y, Andersen CA, Nielsen H. Assessing the accuracy of prediction algorithms for classification: an overview. Bioinformatics. 2000;16:412\u201324.","journal-title":"Bioinformatics"},{"key":"1194_CR54","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert B, Gillette M, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102:15545\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1194_CR55","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1200\/JCO.2003.05.191","volume":"21","author":"B Bernardi De","year":"2003","unstructured":"De Bernardi B, Nicolas B, Boni L, Indolfi P, Carli M, Cordero DM, et al. Disseminated neuroblastoma in children older than one year at diagnosis: comparable results with three consecutive high-dose protocols adopted by the Italian Co-Operative Group for Neuroblastoma. J Clin Oncol. 2003;21:1592\u2013601.","journal-title":"J Clin Oncol"},{"key":"1194_CR56","volume":"3","author":"JT Chi","year":"2006","unstructured":"Chi JT, Wang Z, Nuyten DS, Rodriguez EH, Schaner ME, Salim A, et al. Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancers. PLoS Med. 2006;3:e47.","journal-title":"PLoS Med"},{"key":"1194_CR57","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrc1367","volume":"4","author":"JM Brown","year":"2004","unstructured":"Brown JM, William WR. Exploiting tumour hypoxia in cancer treatment. Nat Rev Cancer. 2004;4:437\u201347.","journal-title":"Nat Rev Cancer"},{"key":"1194_CR58","first-page":"1","volume":"345","author":"A Pietras","year":"2010","unstructured":"Pietras A, Johnsson AS, Pahlman S. The HIF-2alpha-driven pseudo-hypoxic phenotype in tumor aggressiveness, differentiation, and vascularization. Curr Top Microbiol Immunol. 2010;345:1\u201320.","journal-title":"Curr Top Microbiol Immunol"},{"key":"1194_CR59","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nrc3064","volume":"11","author":"WR Wilson","year":"2011","unstructured":"Wilson WR, Hay MP. Targeting hypoxia in cancer therapy. Nat Rev Cancer. 2011;11:393\u2013410.","journal-title":"Nat Rev Cancer"},{"key":"1194_CR60","doi-asserted-by":"crossref","unstructured":"Bosco MC, Varesio L. Hypoxia and Gene Expression. In: Hypoxia and Cancer. Melillo G. Editor. Humana Press; Springer New York; 2014:91\u2013119.","DOI":"10.1007\/978-1-4614-9167-5_5"},{"key":"1194_CR61","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/sj.bjc.6605450","volume":"102","author":"FM Buffa","year":"2010","unstructured":"Buffa FM, Harris AL, West CM, Miller CJ. Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene. Br J Cancer. 2010;102:428\u201335.","journal-title":"Br J Cancer"},{"key":"1194_CR62","doi-asserted-by":"crossref","first-page":"5191","DOI":"10.1158\/1078-0432.CCR-08-2534","volume":"15","author":"AC Hoffmann","year":"2009","unstructured":"Hoffmann AC, Danenberg KD, Taubert H, Danenberg PV, Wuerl P. A three-gene signature for outcome in soft tissue sarcoma. Clin Cancer Res. 2009;15:5191\u20138.","journal-title":"Clin Cancer Res"},{"key":"1194_CR63","doi-asserted-by":"crossref","first-page":"4278","DOI":"10.1158\/1078-0432.CCR-09-3274","volume":"16","author":"H Malenstein van","year":"2010","unstructured":"van Malenstein H, Gevaert O, Libbrecht L, Daemen A, Allemeersch J, Nevens F, et al. A seven-gene set associated with chronic hypoxia of prognostic importance in hepatocellular carcinoma. Clin Cancer Res. 2010;16:4278\u201388.","journal-title":"Clin Cancer Res"},{"key":"1194_CR64","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10462-007-9052-3","volume":"26","author":"SB Kotsiantis","year":"2006","unstructured":"Kotsiantis SB, Zaharakis ID, Pintelas PE. Machine learning: a review of classification and combining techniques. Artif Intell Rev. 2006;26:159\u201390.","journal-title":"Artif Intell Rev"},{"key":"1194_CR65","first-page":"249","volume":"31","author":"SB Kotsiantis","year":"2007","unstructured":"Kotsiantis SB. Supervised Machine Learning: A Review of Classification Techniques. Informatica. 2007;31:249\u201368.","journal-title":"Informatica"},{"issue":"Suppl 7","key":"1194_CR66","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1186\/1471-2105-14-S7-S12","volume":"14","author":"D Cangelosi","year":"2013","unstructured":"Cangelosi D, Blengio F, Versteeg R, Eggert A, Garaventa A, Gambini C, et al. Logic Learning Machine creates explicit and stable rules stratifying neuroblastoma patients. BMC Bioinformatics. 2013;14 Suppl 7:S12.","journal-title":"BMC Bioinformatics"},{"key":"1194_CR67","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1109\/TKDE.2009.206","volume":"23","author":"M Muselli","year":"2011","unstructured":"Muselli M, Ferrari E. Coupling Logical Analysis of Data and Shadow Clustering for Partially Defined Positive Boolean Function Reconstruction. IEEE Trans Knowl Data Eng. 2011;23:37\u201350.","journal-title":"IEEE Trans Knowl Data Eng"},{"issue":"Suppl 4","key":"1194_CR68","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1186\/1471-2105-13-S4-S13","volume":"13","author":"A Cornero","year":"2012","unstructured":"Cornero A, Acquaviva M, Fardin P, Versteeg R, Schramm A, Eva A, et al. Design of a multi-signature ensemble classifier predicting neuroblastoma patients\u2019 outcome. BMC Bioinformatics. 2012;13 Suppl 4:S13.","journal-title":"BMC Bioinformatics"},{"issue":"Suppl 5","key":"1194_CR69","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1634\/theoncologist.9-90005-10","volume":"9","author":"P Vaupel","year":"2004","unstructured":"Vaupel P. The role of hypoxia-induced factors in tumor progression. Oncologist. 2004;9 Suppl 5:10\u20137.","journal-title":"Oncologist"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-016-1194-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,27]],"date-time":"2020-09-27T05:26:38Z","timestamp":1601184398000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/s12859-016-1194-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":69,"journal-issue":{"issue":"S12","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["1194"],"URL":"https:\/\/doi.org\/10.1186\/s12859-016-1194-3","relation":{},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10]]},"article-number":"347"}}